Alison Hunter Memorial Foundation
The Alison Hunter Memorial Foundation (AHMF) was established in 1998 to with the mission "to reduce the impact in the community of the disease Myalgic Encephalomyelitis/Chronic Fatigue Syndrome." The non-profit charity merged in 2014 with the National Centre for Neuroimmunology and Emerging Diseases (N.C.N.E.D.) at Griffith University, Queensland, and thus no longer operates as an independent no-profit charity. Its name honors Alison Hunter, a teen who died following complications from a severe case of myalgic encephalomyelitis(ME).
Notable people[edit | edit source]
Conferences[edit | edit source]
The Alison Hunter Memorial Foundation held International Clinical and Scientific Meetings in 1998, 1999, and 2001. Closed Meetings of invited researchers were held at the University of Adelaide, Adelaide, South Australia in 2005 and 2007. Speakers and topics are available with the following links:
- 2007 ME/CFS Research Forum
- 2005 ME/CFS Research Forum
- 2001 ME/CFS Research Forum
- 1999 Clinical and Scientific Meeting in Syndey
- 1998 Clinical and Scientific Meeting in University of Newcastle, Callaghan, New South Wales
See also[edit | edit source]
References[edit | edit source]
myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.